Support for Vaccine Development
Deadline: 30 Jan 2015 5:00 p.m. CET
Anticipated Decision Date 8 April 2015
The High Impact project on Advanced Immunization Technologies (ADITEC), funded through the 7th Framework Programme of the European Union, aims to accelerate the development of novel and powerful immunization technologies for the next generation of human vaccines. ADITEC is coordinated by the Sclavo Vaccines Association (SVA): a non-profit organization that strives to ensure long-term sustainability of European vaccine R&D efforts.
ADITEC constitutes an important cornerstone of an expanded vaccine research partnership, geared to boost European research in the field of immunology and vaccinology. It is within this context that ADITEC will give interested vaccine R&D users free access to consortium “in house” available vaccinology expertise and technologies.
By facilitating better coordination among European organizations involved in vaccine research, ADITEC hopes to expand European industry capacity in terms of vaccine R&D and production, thus promoting competitiveness of European health industries and significantly impacting population health in the future.
Commissioned research support for European Small and Medium size Enterprises (SME) and Public Health Organizations.
The ADITEC project is looking to support SMEs and public health organizations from within or outside the ADITEC consortium in vaccine development work that will result in public health benefit. We are actively seeking research proposals clearly aimed at vaccine development, where specific support can be requested in the areas listed below. These services are offered by current ADITEC consortium partners and are available free of charge to the requesting SME or public health organization, upon approval of the proposal. ADITEC funding is available and up to 100 k€ of services may requested per project. The ADITEC project will reimburse the service-providing ADITEC partners directly for services provided. There will be no cost to the awarded SME or public health organization for the research services provided. Resulting IP will be owned by the SME or public health organization receiving the service, and maybe shared with the ADITEC partner(s) performing the research. It will be expected that results of the “commissioned research work” will be made available to European users, and the ADITEC support will be acknowledged. Successful external applicants, are expected to become an ADITEC “Affiliated Member” including all respective rights as described in the Affiliated Member Application found here.
General Application Information
For questions regarding any aspect of the submission process, please contact the ADITEC Project Manager Lynn Zimmerman.
Eligible Organizations: European SMEs and Public Health Organizations
- The applicant performs the majority of its work in an institution established in a European Member State or Associated State
- Is an small or medium-sized enterprise (SME, an enterprise which employs fewer than 250 persons and has an annual turnover not exceeding 50 million euro, and/or an annual balance sheet total not exceeding 43 million euro. Additional information on the definition of an SME can be found here.
- Is a Public Health Organization.
- Able to commercialize or openly disseminate the results.
Applicants may submit more than one application, provided each application is scientifically distinct.
This form must be completed with any sections not applicable marked as such. All applications must be completed in English and are not to exceed four pages in length including attachments. Any attachments to your proposal must be submitted in PDF format, filenames must be included in the body of the proposal, and a pdf extension must be used. Applications must be emailed, with “the organization’s name and Commissioned Research Call”, in the subject line of the email. Your application will be acknowledged within 72 hours of receiving your application.
Applications must be successfully received by Lynn Zimmerman and Laura Pacciarini no later than 5:00 p.m. CET on 30 Jan 2015. Under no circumstances will the Management Team accept responsibility for lost emails or consider applications received after the deadline. Applicants are totally responsible for ensuring that their applications are received and acknowledged within the deadline.
In its commitment to adhere to the principles of transparency, fairness and impartiality, a committee of ADITEC partners other than those offering R&D services under the call, will be assembled to review applications both in light of impact relevance for SMEs and public health, consistency with ADITEC programme goals and scientific excellence. In addition, ADITEC’s external advisory group will provide their recommendation on the projects to be chosen. All applicants will be notified via email of the results of their application upon completion of the selection process.
Each recipient entering a funding support agreement with ADITEC will declare its commitment to deliver the reports and necessary documentation in a Letter of Acceptance which will be issued to the User upon positive evaluation of their proposal.
The following items are mandatory and each recipient accessing the ADITEC support services commits to comply with the following requirements:
All reporting content and timeline requirements. This will include, but may not be limited to the submission of organizational information to ADITEC or to the EC, a final report after awarded services are complete, a summary report when the full project is complete and EC required impact survey. Failure to provide any report may result in the awardee being billed for the entire cost of providing the services. The purpose of the report is to highlight the scientific output of the services received and shall be included in the ADITEC reports to the EC. The reports may be published on the ADITEC web site, be highlighted in the ADITEC newsletter or other ADITEC publications. Report templates will be created and distributed at a later date.
An acknowledgement of the ADITEC project must be included in any such publications, “This project has received funding from the European Union’s Seventh Framework Programme for research, technological development and demonstration under grant No. 280873”. All Applicants will send full citations and full text PDF copies of all publications resulting from or involving the work carried out under this award to the ADITEC management team. Any subsequent publications or patents created through the support of the EC funded ADITEC project must be communicated to the ADITEC management team.
The providers for the animal and human models will collect and submit the necessary documentations to ethical committees and regulatory approvals. If a proposal fails to pass the ethical review the animal study cannot be performed and has no obligation to provide the services.
To apply, please complete this application form.